In Mexico, digitalis was known since the 16th century and was used to
treat patients with bloating, and it was not until the 20th century that it
began to be used as a medicine for heart failure. In conjunction with
diuretics. Digitalis was later used in combination individualized with the new
medications, for this purpose and research has shown that the combination of
medications on an individualized basis is what is currently successfully
available for the medical treatment of heart failure.
References
[1]
Guadalajara-Boo, J.F. (2022) Historia Gráfica de la Cardiología Mexicana en el siglo XX. Méndez Editores, Mexico City.
[2]
Chávez, I. (1920) La digitalina a pequeñas dosis, en el tratamiento de las cardiopatías. Tesis recepcional. Facultad de Medicina. Universidad Nacional Autónoma de México.
[3]
Braunwald, E., Goldberg, L.I. and Morrow, A.G. (1961) Studies on Digitalis. IV. Observations in Man on the Effects of Digitalis Preparations on the Contractility of the Non-Failing Heart and on Total Vascular Resistance. Journal of Clinical Investigation, 4, 52-59. https://doi.org/10.1172/JCI104236
[4]
Mason, D.T. and Braunwald, E. (1964) Studies on Digitalis. X. Effects of Ouabain on Forearm Vascular Resistance and Venous Tone in Normal Subjets and in Patients in Heart Failure. Journal of Clinical Investigation, 43, 532-538. https://doi.org/10.1172/JCI104939
[5]
Vatner, S.F. and Braunwald, E. (1974) Effects of Chronic Heart Failure on the Inotropic Response of the Right Ventricle of the Conscious Dog to a Cardiac Glycoside and to Tachycardia. Circulation, 50, 728-734. https://doi.org/10.1161/01.CIR.50.4.728
[6]
Braunwald, E. (1971) Control of Myocardial Oxygen Consumption: Physiologic and Clinical Considerations. The American Journal of Cardiology, 27, 416-432. https://doi.org/10.1016/0002-9149(71)90439-5
[7]
Covell, J.W., Braunwald, E., Ross, I. and Sonnenblick, E.H. (1966) Studies on Digitalis. XVI Effects on Myocardial Oxygen Consumption. Journal of Clinical Investigation, 45, 1535-1541. https://doi.org/10.1172/JCI105460
[8]
The Digitalis Investigation Group Investigators (1997) The Effects of Digoxin on Mortality and Morbidity in Patient Whit Heart Failure. The New England Journal of Medicine, 336, 525-533. https://doi.org/10.1056/NEJM199702203360801
[9]
Volpi, A., De Vita, C., Franzoci, M.G., Geraci, E., Mauri, F., Negri, E., et al. (1993) Determinant of Six-Monts Mortality in Survivors of Myocardial Infarction Alter Thrombolisys Results of the GISSI-2 Database. Circulation, 88, 416-429. https://doi.org/10.1161/01.CIR.88.2.416
[10]
Curtis, J.P., Sokil, S.I., Wang, Y., Rathore, S.S., Ka, D.T. and Jadbaba, F. (2003) The Association of Left Ventricular Ejection Fraction Mortality as Cause of Death in Stable out Patients with Heart Failure. Journal of the American College of Cardiology, 42, 736-742. https://doi.org/10.1016/S0735-1097(03)00789-7
[11]
Aronow, W.S., Ahn, C. and Kronson, I. (1990) Prognosis of Congestive Heart Failure in Elderly Patient in Normal vs Abnormal Left Ventricular Systolic Function Associated with Coronary Artery Disease. The American Journal of Cardiology, 66, 1257-1259. https://doi.org/10.1016/0002-9149(90)91112-J
[12]
Cohn, J.N. and Rector, T.S. (1988) Prognosis of Congestive Heart Failure and Predictors on Mortality. The American Journal of Cardiology, 62, 25A-30A. https://doi.org/10.1016/S0002-9149(88)80081-X
[13]
Gheorghiade, M., Patel, K., Filippatos, N.G., Anker, S.D., Van Veldhuisen, D.J., Cleland, J.G.F., et al. (2013) Effect of Oral Digoxin in High-Risk Heart Failure Patients: A Pre-Specified Subgroup Analysis of the DIG Trial. European Journal of Heart Failure, 15, 551-559. https://doi.org/10.1093/eurjhf/hft010
[14]
Gheorghiade, M. and Braumwald, E. (2009) Recopnsidering the Role for Digoxin in the Management of Acure Heart Failure Síndromes. JAMA, 302, 2146-2147. https://doi.org/10.1001/jama.2009.1657
[15]
Tauke, J., Goldstein, S. and Gheorghiade, M. (1994) Digoxin in Chronic Heart Failure: A Review of Randomized Controlled Trials with Special Attention to the Proved and Radiance Trial. Progress in Cardiovascular Diseases, 37, 49-58. https://doi.org/10.1016/S0033-0620(05)80051-9
[16]
Gheorghiade, M. and Ferguson, D. (1991) Digoxin. A Neurohormonal Modulatior in Heart Failure. Circulation, 84, 2181-2186. https://doi.org/10.1161/01.CIR.84.5.2181
[17]
Ferrari, A., Gregorini, L., Ferrari, M.C., Preti, L. and Mancia, G. (1981) Digitalis and Baroreceptor Reflexes in Man. Circulation, 63, 279-285. https://doi.org/10.1161/01.CIR.63.2.279
[18]
Mahler, F., Yoran, C. and Ross Jr., J. (1974) Inotropic Effect of Tachycardia and Post Stimulation Potentation in Conscious Dog. American Journal of Physiology-Legacy Content, 227, 569-575. https://doi.org/10.1152/ajplegacy.1974.227.3.569
[19]
Hasenfuss, G., Holubarsch, C., Herman, H.P., Pieske, A.B. and Just, H. (1994) Influence of the Force-Frecuency Relationship on Hemodinamics and Left Ventricular Function in Patients with Non-Failure Hearts and in Patients with Dilated Cardiomyopathy. European Heart Journal, 15, 164-170. https://doi.org/10.1093/oxfordjournals.eurheartj.a060471
[20]
Packer, M., Fowler, M.B., Roecker, E.B., Coats, A.J.S., Katus, H.A. and Krum, H. (2002) Effect of Carvedilol on the Morbidity of Patients with Severe Chronic Heart Failure. Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study. Circulation, 106, 2194-2199. https://doi.org/10.1161/01.CIR.0000035653.72855.BF
